摘要
近几年来我国大力发展中医药事业,经典名方作为中医药传承发展的突破口,其研究及开发更是受到了很多关注。本研究将就中药经典名方研究进展、开发策略及发中遇到的问题进行分析探讨。查阅国内外相关文献,对所的资料进行整理分析、归纳总结。中药经典名方在发展过程中遇到了许多问题,我国都在积极的协调与解决,且在各方面都小有成就。虽然我国对于经典名方的研究过程还不算太长,但是通过文献检索可以看出,学术各界都在积极响应,且市场和临床上均已经出现了一些由经典名方研发的药物和使用案例,由此可以侧面看出我国对中医中药的复兴的战略也正在稳步迈进。
In recent years,China has made great efforts to develop the cause of traditional Chinese medicine.As a breakthrough in the inheritance and development of traditional Chinese medicine,the research and development of classical prescriptions has attracted much attention.This study analyzes and discusses the research progress,development strategies and problems encountered in this field by consulting,sorting out,analyzing and summarizing the relevant literature at home and abroad.The results indicate though there exist many problems in the development of traditional Chinese medicine classical prescriptions,the government is actively coordinating the various parties to solving these problem and has made a few achievements in certain aspects.Although the research process of classic prescriptions in China is not too long,it can be seen from the literature review that all the academic circles are responding positively,and some drugs developed from the classical prescriptions have been produced by the market and used in clinic.From this,it can be seen that the rivival strategy of traditional Chinese medicine in China is just moving forward steadily.
作者
高树葳
邱智东
赵燕
高英鑫
徐伟
贾艾玲
李思宁
董雪莲
GAO Shuwei;QIU Zhidong;ZHAO Yan;GAO Yingxin;XU Wei;JIA Ailing;LI Sining;DONG Xuelian(Changchun University of Chinese Medicine;Lanzhou Heshengtang Pharmaceutical Co.Ltd,Lanzhou 730000,China)
出处
《长春中医药大学学报》
2021年第3期674-677,共4页
Journal of Changchun University of Chinese Medicine
基金
吉林省科技发展计划项目(20190304077YY,20200404091YY)。
关键词
经典名方
研究进展
开发策略
classical famous prescriptions
research progress
development strategy